Restoring Insulin Secretion Pediatric Medication Study

Trial Profile

Restoring Insulin Secretion Pediatric Medication Study

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 25 Jun 2018

At a glance

  • Drugs Insulin glargine (Primary) ; Metformin (Primary)
  • Indications Prediabetic-state; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms RISE Peds
  • Most Recent Events

    • 25 Jun 2018 Primary endpoint (B-cell function measured by hyperglycemic clamp techniques: clamp-derived steady-state C-peptide and ACPRmax at 15 months (both evaluated jointly with M/I; co-primary outcomes)) has not been met, according to results published in the Diabetes Care Journal.
    • 25 Jun 2018 According to results published in the Diabetes Care Journal, this trial was trial funded by the National Institute of Diabetes and Digestive and Kidney Diseases.
    • 25 Jun 2018 Results published in the Diabetes Care Journal.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top